Literature DB >> 17714848

Cellular knock-down of quinone reductase 2: a laborious road to successful inhibition by RNA interference.

Pascale Chomarat1, Francis Cogé, Sophie P Guénin, François Mailliet, Fanny Vella, Catherine Mallet, Stéphanie Giraudet, Nadine Nagel, Stéphane Leonce, Gilles Ferry, Philippe Delagrange, Jean A Boutin.   

Abstract

NRH:quinone oxidoreductase 2 (QR2) is a long forgotten oxidoreductive enzyme that metabolizes quinones and binds melatonin. We used the potency of the RNA interference (RNAi)-mediated gene silencing to build a cellular model in which the role of QR2 could be studied. Because standard approaches were poorly successful, we successively used: (1) two chemically synthesized fluorescent small interfering RNA (siRNA) duplexes designed and tested for their gene silencing capacity leading to a maximal 40% QR2 gene silencing 48h post-transfection; (2) double transfection and cell-sorting of high fluorescent siRNA-transfected HT22 cells further enhancing QR2 RNAi silencing to 88%; (3) stable QR2 knock-down HT22 cell lines established with H1and U6 promoter driven QR2 short hairpin RNA (shRNA) encoding vectors, resulting in a 71-80% reduction of QR2 enzymatic activity in both QR2 shRNA HT22 cells. Finally, as a first step in the study of this cellular model, we observed a 42-48% reduction of menadione/BNAH-mediated toxicity in QR2 shRNA cells compared to the wild-type HT22 cells. Although becoming widespread and in some cases effective, siRNA-mediated cellular knock-down proves in the present work to be of marginal efficiency. Much development is required for this technique to be of general application.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714848     DOI: 10.1016/j.biochi.2007.07.004

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

1.  X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.

Authors:  Scott D Pegan; Megan Sturdy; Gilles Ferry; Philippe Delagrange; Jean A Boutin; Andrew D Mesecar
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

Review 2.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

3.  Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.

Authors:  Barbara Calamini; Bernard D Santarsiero; Jean A Boutin; Andrew D Mesecar
Journal:  Biochem J       Date:  2008-07-01       Impact factor: 3.857

4.  Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Liana F Zainullina; Ilya O Logvinov; Ekaterina R Verbovaya; Tatyana A Antipova; Yulia V Vakhitova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

5.  Apigenin and Luteolin Regulate Autophagy by Targeting NRH-Quinone Oxidoreductase 2 in Liver Cells.

Authors:  Elzbieta Janda; Concetta Martino; Concetta Riillo; Maddalena Parafati; Antonella Lascala; Vincenzo Mollace; Jean A Boutin
Journal:  Antioxidants (Basel)       Date:  2021-05-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.